<DrugInformationSummary id="CDR0000816536"><DrugInfoMetaData><DrugInfoType>Brief</DrugInfoType><DrugInfoAudience>Patients</DrugInfoAudience><DrugInfoDescription>Vorasidenib citrate works by entering the brain and blocking the activity of abnormal IDH1 and IDH2 enzymes produced by IDH1 and IDH2 genes with certain mutations. By blocking these enzymes, vorasidenib citrate helps slow or stop the growth of certain types of brain tumors. It is a small-molecule drug (a drug that can enter cells easily).</DrugInfoDescription><DrugInfoURL xref="https://www.cancer.gov/about-cancer/treatment/drugs/vorasidenib-citrate">Vorasidenib Citrate</DrugInfoURL><FDAApproved>Yes</FDAApproved><TerminologyLink ref="CDR0000774431">vorasidenib citrate</TerminologyLink><GlossaryLink ref="CDR0000816538">vorasidenib citrate</GlossaryLink><USBrandNames><USBrandName>Voranigo</USBrandName></USBrandNames><PronunciationInfo><TermPronunciation>vor-uh-SIH-deh-nib SIH-trayt</TermPronunciation><MediaLink ref="CDR0000817405" type="audio/mpeg" alt="" language="en" id="_3"/><MediaLink ref="CDR0000817406" type="audio/mpeg" alt="" language="es" id="_4"/></PronunciationInfo><FDAExternalRef xref="https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=31405fee-55b7-4857-987e-2724ee76be84&amp;audience=consumer">FDA label information for this drug is available at DailyMed.</FDAExternalRef></DrugInfoMetaData><DrugInfoTitle>Vorasidenib Citrate</DrugInfoTitle><Section id="_FDA"><Para><ExternalRef xref="https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=31405fee-55b7-4857-987e-2724ee76be84&amp;audience=consumer">FDA label information for this drug is available at DailyMed.</ExternalRef></Para></Section><Section id="_1"><Title>Use in Cancer</Title>                                                              
  <Para id="_2">Vorasidenib citrate
         is approved to treat:</Para>                          
  <ItemizedList Style="bullet" id="_3">
   <ListItem><Strong><GlossaryTermRef href="CDR0000045602" dictionary="Cancer.gov" audience="Patient">astrocytoma</GlossaryTermRef></Strong> or <Strong><GlossaryTermRef href="CDR0000046257" dictionary="Cancer.gov" audience="Patient">oligodendroglioma</GlossaryTermRef></Strong> in adults and children aged 12 years and older that is <GlossaryTermRef href="CDR0000774694" dictionary="Cancer.gov" audience="Patient">grade</GlossaryTermRef> 2, has an abnormal <GeneName><GlossaryTermRef href="CDR0000794150" dictionary="Cancer.gov" audience="Patient">IDH1</GlossaryTermRef></GeneName> or <GeneName><GlossaryTermRef href="CDR0000790620" dictionary="Cancer.gov" audience="Patient">IDH2</GlossaryTermRef></GeneName> gene, and has been treated with surgery, including biopsy, to partially or completely remove the tumor.</ListItem>
   </ItemizedList>
  <Para id="_5">Vorasidenib citrate
         is also being studied in the treatment of other types of
         cancer.</Para>
 </Section><Section id="_About"><Title>More About Vorasidenib Citrate</Title><Para id="_Dict_1"><ExternalRef xref="https://www.cancer.gov/publications/dictionaries/cancer-drug/def/774431">Definition from the NCI Drug Dictionary</ExternalRef> - Detailed scientific definition and other names for this drug.</Para></Section><Section id="_Research"><Title>Research Results and Related Resources</Title><Para><ExternalRef xref="https://www.cancer.gov/news-events/cancer-currents-blog/2023/low-grade-glioma-optimum">Engaging People with Low-Grade Glioma in Cancer Research</ExternalRef></Para><Para><ExternalRef xref="https://www.cancer.gov/news-events/cancer-currents-blog/2023/vorasidenib-low-grade-glioma-idh-mutations">Vorasidenib Treatment Shows Promise for Some Low-Grade Gliomas</ExternalRef></Para><Para><ExternalRef xref="https://www.cancer.gov/about-cancer/treatment/types/targeted-therapies">Targeted Therapy to Treat Cancer</ExternalRef></Para></Section><Section id="_ClinicalTrial_1"><Title>Clinical Trials Accepting Patients</Title><Para id="_ClinicalTrial_2"><ExternalRef xref="https://www.cancer.gov/research/participate/clinical-trials/intervention/C174942">Find Clinical Trials for Vorasidenib Citrate</ExternalRef> - Check for trials from NCI's list of cancer clinical trials now accepting patients.</Para></Section> 
  <DrugInfoDisclaimer>


<Para id="_Disclaimer_4"><Strong>Important: </Strong>The drug information on this page is meant to be educational. It is not a substitute for medical advice. The information may not cover all possible uses, actions, interactions, or side effects of this drug, or precautions to be taken while using it. Please see your health care professional for more information about your specific medical condition and the use of this drug.
</Para></DrugInfoDisclaimer> 
  <DateFirstPublished>2024-08-21</DateFirstPublished></DrugInformationSummary>
